Search details
1.
Monitoring skin dose changes during image-guided helical tomotherapy for head and neck cancer patients.
Strahlenther Onkol
; 196(3): 243-251, 2020 Mar.
Article
in English
| MEDLINE | ID: mdl-31586231
2.
Predictive value of a proteomic signature in patients with non-small-cell lung cancer treated with second-line erlotinib or chemotherapy (PROSE): a biomarker-stratified, randomised phase 3 trial.
Lancet Oncol
; 15(7): 713-21, 2014 Jun.
Article
in English
| MEDLINE | ID: mdl-24831979
3.
Immunotherapy in small bowel adenocarcinoma: a potential role?
Immunol Med
; 47(1): 1-5, 2024 Mar.
Article
in English
| MEDLINE | ID: mdl-37293784
4.
Durvalumab Plus Gemcitabine and Cisplatin Versus Gemcitabine and Cisplatin in Biliary Tract Cancer: a Real-World Retrospective, Multicenter Study.
Target Oncol
; 19(3): 359-370, 2024 May.
Article
in English
| MEDLINE | ID: mdl-38691295
5.
Innovative cooking techniques in a hospital food service: Effects on the quality of hospital meals.
Nutrition
; 93: 111487, 2022 Jan.
Article
in English
| MEDLINE | ID: mdl-34655953
6.
Does immunotherapy change the treatment paradigm in metastatic gastric cancer?
Med Oncol
; 39(12): 224, 2022 Sep 29.
Article
in English
| MEDLINE | ID: mdl-36175723
7.
Treatment of Metastasized Prostate Cancer Beyond Progression After Upfront Docetaxel-A Real-world Data Assessment.
Eur Urol Focus
; 7(6): 1308-1315, 2021 Nov.
Article
in English
| MEDLINE | ID: mdl-32653263
8.
A real-world comparison of docetaxel versus abiraterone acetate for metastatic hormone-sensitive prostate cancer.
Cancer Med
; 10(18): 6354-6364, 2021 09.
Article
in English
| MEDLINE | ID: mdl-34374489
9.
Whole-body Diffusion-weighted Magnetic Resonance Imaging for Assessment of the Bone Response Rate in Patients with Metastatic Hormone-sensitive Prostate Cancer Receiving Enzalutamide.
Eur Urol
; 2024 May 20.
Article
in English
| MEDLINE | ID: mdl-38772788
Results
1 -
9
de 9
1
Next >
>>